Aimed Bio에임드바이오

Aimed Bio0009K0· Biotech & PharmaInitiation

Aimed Bio: High-Margin Earnings on a Small Base, With a Share Price Well Above the Model Estimate

Aimed Bio, a KOSDAQ-listed biotech listed on 2025-12-04, closed at ₩22,200 for a market cap of about ₩1.4T. Filed financials show a 43.9% operating margin but only 10.6% net margin and 2.5% ROE, and the DCF model estimate per share is below the current price.

Oct 13, 20260 views